However, in metastatic melanoma, melanoma cells typically express PD-L1, and the addition of interferon-γ stimulation increases exosomal PD-L1 levels; this results in the inhibition of CD8 T-cell function and promotes tumor growth, which explains the resistance to PD-1 and treatment failure observed in many patients. Here, PDCD1 is linked to melanoma.